U.S. Markets close in 11 mins
  • S&P 500

    3,608.75
    -31.72 (-0.87%)
     
  • Dow 30

    28,884.21
    -341.40 (-1.17%)
     
  • Nasdaq

    10,648.50
    -89.01 (-0.83%)
     
  • Russell 2000

    1,672.24
    -2.69 (-0.16%)
     
  • Crude Oil

    79.80
    -1.43 (-1.76%)
     
  • Gold

    1,669.50
    +0.90 (+0.05%)
     
  • Silver

    19.01
    +0.30 (+1.62%)
     
  • EUR/USD

    0.9806
    -0.0013 (-0.1373%)
     
  • 10-Yr Bond

    3.8040
    +0.0570 (+1.52%)
     
  • Vix

    31.62
    -0.22 (-0.69%)
     
  • GBP/USD

    1.1167
    +0.0044 (+0.3953%)
     
  • USD/JPY

    144.7470
    +0.3040 (+0.2105%)
     
  • BTC-USD

    19,716.25
    +309.48 (+1.59%)
     
  • CMC Crypto 200

    450.08
    +6.65 (+1.50%)
     
  • FTSE 100

    6,893.81
    +12.22 (+0.18%)
     
  • Nikkei 225

    25,937.21
    -484.84 (-1.83%)
     

Baxter to Present at the Raymond James 43rd Annual Institutional Investors Conference

·1 min read

DEERFIELD, Ill., February 22, 2022--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Raymond James 43rd Annual Institutional Investors Conference on Monday, March 7, 2022. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 8:40 a.m. Eastern Time.

The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through March 6, 2023.

About Baxter

Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of diagnostic, critical care, kidney care, nutrition, hospital and surgical products used across patient homes, hospitals, physician offices and other sites of care. For 90 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, digital health solutions and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxter.com and follow us on Twitter, LinkedIn and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220222006035/en/

Contacts

Media Contact
Steve Brett, (224) 948-5353
media@baxter.com

Investor Contact
Clare Trachtman, (224) 948-3020